This is the story of our research.
On this page you will find a selection of our work in almost every area of health and care including the challenges we are working to address, the nature of our research, and the difference we have made to peoples' lives. One of our public contributors suggested that our evidence should 'enable people to be born well, live well, and die well'. We agree. This is at the heart of what we seek to achieve.
The MOAM trial is the first ever large-scale trial of treatment for offenders with antisocial personality disorder. It provides an excellent demonstration of the impact of patient and public involvement in research.
NIHR trial finds that a single dose of preventative prophylactic antibiotics, halves the risk of infection for women who have assisted vaginal births.
A dramatic 800 calorie a day diet that has been shown to reverse diabetes is currently being piloted in the NHS across England. This follows a successful NIHR-funded trial that showed the effectiveness of the liquid diet and a larger trial into how the diet could be rolled out into everyday practice.
A quick bedside test can deliver diagnosis of respiratory virus infection in children and allow clinicians to treat patients while protecting others from infection. Results from recent trials could change care pathways in the future.
It is possible to reduce the number of pneumococcal vaccines given to babies and children without increasing their risk of serious and fatal infections. An NIHR-funded trial demonstrated that fewer injections can deliver immunity in the UK, leading to the government changing the pneumococcal vaccine schedule from three doses to two.
A 20 minute measurement test for Attention Deficit Hyperactivity Disorder (ADHD) has transformed the experience of patients and clinicians across the East Midlands and is being rolled out across the country.
Researchers funded by the NIHR School for Public Health Research explored how working with a wholesale supplier could encourage fish and chip shops to offer smaller portion sizes to customers.
NIHR researchers compare self-managed computer therapy programme to usual speech and language therapy
Avastin, a drug that treats neovascular age-related macular degeneration, could save the NHS millions
The NIHR-funded WOLLF study set out to find the best wound dressing for open fractures.